| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17:42 | Custodian Property Income REIT buys back 150,000 shares at 82.5p | ||
| 17:42 | REV Group Q4 2025 presentation: margin expansion drives record results ahead of Terex merger | ||
| 17:42 | Palantir stock secures $446 million U.S. Navy contract for submarine production | ||
| 17:18 | CQS New City High Yield Fund to issue 500,000 new shares at 51.2p | ||
| 17:18 | North Dallas Bank & Trust declares $0.10 per share dividend | ||
| 17:18 | Invesco cuts stake in PRS REIT to below 1% | ||
| 17:18 | Atlas Holdings completes $1 billion acquisition of ODP Corporation | ||
| 17:18 | VersaBank Q4 2025 slides: US expansion drives 91% adjusted profit growth | ||
| 17:18 | Old Mutual share trusts purchase R83.7 million in shares for employee plans | ||
| 17:18 | Hello Group stock price target lowered to $8.10 at Jefferies on softer domestic outlook | ||
| 17:18 | Jefferies raises Terns Pharmaceuticals stock price target to $70 on CML data | ||
| 17:18 | UBS raises G-III Apparel stock price target to $32 on brand strength | ||
| 17:18 | UBS lowers AutoZone stock price target on elevated investment spending | ||
| 17:18 | Campbell Soup stock price target lowered to $26 by UBS on weak outlook | ||
| 17:18 | Ollie's Bargain Outlet stock price target lowered to $130 at UBS | ||
| 17:18 | Designer Brands stock price target raised to $7.00 from $4.50 at UBS | ||
| 17:18 | SBA Communications stock price target maintained at $275 by UBS | ||
| 17:18 | Nike stock faces slow recovery, UBS maintains neutral rating | ||
| 17:18 | Boeing stock delivers 44 aircraft in December, UBS maintains Buy rating | ||
| 16:30 | Perpetual Limited crosses 5% ownership threshold in Oxford Metrics | ||
| 16:30 | CrowdStrike scores perfect marks in MITRE's cross-domain attack test | ||
| 16:30 | Casey's Q2 2026 investor slides: exceeding growth targets despite stock dip | ||
| 16:30 | Photronics Q4 2025 slides: Record IC revenue drives earnings beat, stock surges | ||
| 16:30 | Citadel Group discloses 1.22% stake in Avadel Pharmaceuticals | ||
| 16:30 | Bruker stock steady as Leerink Partners reiterates Outperform rating |